35 Year Anniversary of Generic Medicines @accessiblemeds
35 Year Anniversary of Generic Medicines  @accessiblemeds
Uploaded October 2019 | Updated November 2026, 1 hour ago
On September 24, President Ronald Reagan signed the Drug Price Competition and Patent Term Restoration Act. Better known by the name of its two sponsors, Senator Orrin Hatch (R-UT) and Representative Henry Waxman (D-CA), the Hatch-Waxman Amendments gave rise to the modern generic pharmaceutical industry as we know it.

“Fact is,” the president said, “it's estimated that consumers will save more than a billion dollars over the next 10 years.” This savings turned out to be much larger and have continued to grow since then.
Last year, according to AAM’s Access & Savings Report, generic savings for consumers and the U.S. health care system totaled $293 billion, and the 2008-18 savings hit $2 trillion. These are the savings realized by patients taking lower-priced generics instead of the equivalent brand medicine.

Learn more about savings from generic medicines at http://rxaccessreport.org.
35 Year Anniversary of Generic MedicinesGDUFA/BsUFA User Fees ExplainedSavings from Biosimilars since 2015 #GRxBiosimsSavingsReportBriefing: How NAFTA/Trade Policy Proposals Undermine Trump Administration Drug Pricing BlueprintAAM Lifetime Achievement Award - Joe RennerJoin us a GRx+Biosims 2021 — Progress + ProcessAAM Lifetime Achievement Award at Access! 2022GRx+Biosims 2022Christine Simmon: Policy and Biosimilars Sessions at the GRx+Biosims 2020 Virtual ConferencePatient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeekGeneric Drugs Are the Prescription for Savings. Dont Take Them for Granted.The Generics and Biosimilars Industry Has a Plan to Secure Our Medicines — #SecureOurMeds
Association for Accessible Medicines |

35 Year Anniversary of Generic Medicines

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER